
Aktiviere Job-Benachrichtigungen per E-Mail!
Erstelle in nur wenigen Minuten einen maßgeschneiderten Lebenslauf
Überzeuge Recruiter und verdiene mehr Geld. Mehr erfahren
A leading biotech startup in Germany is seeking a CMC Development Manager to advance an innovative drug development program. The candidate will lead process development, manage analytical methods validation, and ensure compliance with quality standards. This position offers a competitive salary, stock options, and the flexibility of remote or hybrid work. Ideal candidates will have an MSc or PhD in a relevant field and significant experience in the pharmaceutical industry. Join us in making impactful advancements in cancer treatment!
As a CMC Development Manager (m / f / d), you will be a key leader in advancing our innovative drug development program. You will take ownership of the development of our products, from analytical method development and validation to drug substance and drug product manufacturing processes optimization. Working closely with multidisciplinary teams and external partners, you will ensure our processes and products meet the highest standards of quality, scalability, and regulatory compliance.
Join us in making a difference! Submit your application to be considered for this exciting opportunity.
Any questions? Please contact :
Emilija Stojanovska
Sr. Talent Acquisition Manager
mail : careers@nvision-imaging.com
NVision is a quantum biotech startup based in Ulm, Germany, with Tier 1 investors from the USA and Europe. We are just leaving stealth mode, moving from local R&D to global commercialization and expansion.
We are developing a technology that will enable MRI-based imaging of real-time metabolism in the body, with tremendous potential for research and applications in oncology, cardiology, neurology and more. Our company brings together expertise in physics, chemistry, engineering and medicine, and we are collaborating with scientists and clinicians from top medical and research centers such as Memorial Sloan Kettering in New York, MD Anderson in Texas, Technical University of Munich, Cambridge University in the UK and more.
NVision is developing fast, robust and easy-to-use hyperpolarization technology for preclinical and clinical research in our POLARIS product line. Those devices are placed close to an MRI scanner in a research or clinical environment to produce hyperpolarized contrast agents on demand in a fast, fully-automated, multi-step chemical process. Key steps of the process contain fluidic transport across multiple vessels and chemical mixing and separation processes in fully-reuseable or single-use disposable fluid paths. We develop our commercial products jointly with external design and manufacturing partners and the process development as well as the design and manufacturing of prototypes is done entirely in-house.
We offer a dynamic international working environment, with immense room for growth, that encourages personal initiative and open communication.
Please note that, for data privacy reasons, we’ll not review applications or CVs sent via email. Unsolicited applications can be submitted here.